Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.
Karnovsky
M J
MJ
Department of Pathology, Harvard Medical School, Boston, Massachusetts.
Wright
T C
TC
Castellot
J J
JJ
Choay
J
J
Lormeau
J C
JC
Petitou
M
M
D000818:Animals; D000990:Antithrombin III / Q000378:metabolism; D001161:Arteriosclerosis / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D004730:Endothelium, Vascular / Q000473:pathology; D006025:Glycosaminoglycans / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology*; D006497:Heparan Sulfate / Q000494:pharmacology*; D015394:Molecular Structure; D009131:Muscle, Smooth, Vascular / Q000473:pathology*; D013329:Structure-Activity Relationship; D013431:Sulfates / Q000378:metabolism
D000990:Antithrombin III; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; D013431:Sulfates